A retrospective observational study of LDL-C, CV risk and costs reduction among a cohort of patients with a recent myocardial infarction in Spain
Latest Information Update: 02 Dec 2021
At a glance
- Drugs Evolocumab (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 02 Dec 2021 New trial record